VeriMom¿Es bacillus/monascus/capsella bursa-pastoris leaf/rice bran ferment filtrate seguro durante el embarazo?
No EU Annex II/III listing or harmonised CMR classification was found for Monascus- or rice-ferment filtrates and no SCCS/CIR reproductive restrictions were identified; an oral developmental toxicity study of Monascus red in rats reported a NOAEL at the highest tested dose (5.00 g/kg bw) with no embryo‑fetal effects. Topical cosmetic use therefore shows no reproductive hazard signal but dermal absorption data are limited, so low but measurable systemic exposure is assumed for pregnancy. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/39900205/))
Related ingredients
Frequently asked questions
- ¿Es bacillus/monascus/capsella bursa-pastoris leaf/rice bran ferment filtrate seguro durante el embarazo?
- No EU Annex II/III listing or harmonised CMR classification was found for Monascus- or rice-ferment filtrates and no SCCS/CIR reproductive restrictions were identified; an oral developmental toxicity study of Monascus red in rats reported a NOAEL at the highest tested dose (5.00 g/kg bw) with no embryo‑fetal effects. Topical cosmetic use therefore shows no reproductive hazard signal but dermal absorption data are limited, so low but measurable systemic exposure is assumed for pregnancy. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/39900205/))
- ¿Es bacillus/monascus/capsella bursa-pastoris leaf/rice bran ferment filtrate seguro durante la lactancia?
- Same regulatory and toxicology picture as for pregnancy: no harmonised CMR codes or EU bans/restrictions and available animal oral data did not show developmental toxicity; breastfeeding risk from topical cosmetic use is therefore judged low but measurable due to limited dermal absorption data. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/39900205/))
- ¿Es bacillus/monascus/capsella bursa-pastoris leaf/rice bran ferment filtrate seguro para la piel del bebé?
- No evidence of intrinsic reproductive or developmental hazard for the ferment filtrate itself (no Annex II/III, no harmonised H‑statements, and no dermal developmental studies). Because infants (0–3 yr) have higher skin permeability and immature barrier function, exposure score is increased by +1 versus adult; this assumes the ingredient is not completely non‑absorbable. No infant‑specific toxicity or topical developmental studies were identified. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/39900205/))
- ¿Cómo puntúa VeriMom a bacillus/monascus/capsella bursa-pastoris leaf/rice bran ferment filtrate?
- VeriMom puntúa bacillus/monascus/capsella bursa-pastoris leaf/rice bran ferment filtrate en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a bacillus/monascus/capsella bursa-pastoris leaf/rice bran ferment filtrate en el embarazo?
- Consulta nuestra lista de alternativas seguras a bacillus/monascus/capsella bursa-pastoris leaf/rice bran ferment filtrate según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.